Transmembrane protein 225 (TMEM225) is a protein localized to the cellular membrane, particularly in the endoplasmic reticulum (ER) and Golgi apparatus. Despite limited characterization, emerging evidence suggests that TMEM225 may play essential roles in intracellular membrane trafficking and protein sorting processes within the secretory pathway. Its specific function remains largely elusive, but its subcellular localization hints at involvement in protein transport and membrane organization. Moreover, TMEM225's presence in membrane-bound compartments suggests a possible role in mediating interactions between vesicular transport machinery and membrane-associated proteins, thereby contributing to the regulation of cellular trafficking events crucial for maintaining organelle function and cellular homeostasis.
The activation mechanisms governing TMEM225 are yet to be fully elucidated, reflecting the current gaps in our understanding of its biological function. However, considering its localization to membrane-bound organelles, TMEM225 activation is likely regulated by complex signaling cascades and protein-protein interactions that govern intracellular membrane dynamics. One plausible mechanism of activation involves post-translational modifications, such as phosphorylation or glycosylation, which can modulate TMEM225's stability, subcellular localization, and interactions with binding partners. Additionally, TMEM225 activation may be influenced by environmental cues and cellular stress responses, as alterations in cellular conditions can impact membrane trafficking processes and necessitate adaptive changes in protein localization and activity. Furthermore, the identification of TMEM225-interacting proteins and regulatory factors may provide insights into the molecular mechanisms underlying its activation and function in intracellular membrane dynamics. Overall, further investigation is warranted to unravel the precise mechanisms governing TMEM225 activation and its role in cellular physiology and organelle homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a potent activator of adenylyl cyclase, an enzyme that increases the levels of cyclic adenosine monophosphate (cAMP) in cells. The elevated cAMP levels activate protein kinase A (PKA), which can phosphorylate and activate TMEM225. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, enzymes that degrade cAMP. By inhibiting these enzymes, IBMX increases intracellular cAMP levels, indirectly leading to the activation of TMEM225 via the PKA pathway. | ||||||
Uridine-5′-triphosphate, Trisodium Salt | 19817-92-6 | sc-301964 sc-301964A | 50 mg 1 g | $88.00 $120.00 | 2 | |
UTP activates P2Y receptors, triggering G protein-coupled receptor pathways. This leads to phospholipase C activation, resulting in the production of inositol trisphosphate (IP3) and diacylglycerol (DAG) which can activate TMEM225. | ||||||
ADP | 58-64-0 | sc-507362 | 5 g | $54.00 | ||
ATP also activates P2Y receptors, leading to the production of IP3 and DAG through the phospholipase C pathway, indirectly enhancing the activity of TMEM225. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits the sodium-potassium ATPase pump, leading to an increase in intracellular calcium levels. The elevated calcium levels can activate TMEM225. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), causing an increase in cytosolic calcium levels. This increase can activate TMEM225. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium concentration, which can activate TMEM225. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $46.00 $61.00 $117.00 $173.00 $530.00 | 36 | |
Glyburide inhibits ATP-sensitive K+ channels, resulting in membrane depolarization and the opening of voltage-gated calcium channels, which can enhance the activity of TMEM225. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker that can modify intracellular calcium levels, indirectly leading to the activation of TMEM225. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeant calcium chelator that can modify intracellular calcium levels, indirectly leading to the activation of TMEM225. | ||||||